Application Nr Approved Date Route Status External Links
ANDA076410 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zolpidem Tartrate Tablets Usp Are Indicated For The Short-Term Treatment Of Insomnia Characterized By Difficulties With Sleep Initiation. Zolpidem Tartrate Tablets Usp Have Been Shown To Decrease Sleep Latency For Up To 35 Days In Controlled Clinical Studies [ See Clinical Studies ( 14 ) ]. The Clinical Trials Performed In Support Of Efficacy Were 4 To 5 Weeks In Duration With The Final Formal Assessments Of Sleep Latency Performed At The End Of Treatment. Zolpidem Tartrate Tablets Usp, A Gamma-Aminobutyric Acid (Gaba) A Agonist, Are Indicated For The Short-Term Treatment Of Insomnia Characterized By Difficulties With Sleep Initiation. Zolpidem Tartrate Tablets Usp Have Been Shown To Decrease Sleep Latency For Up To 35 Days In Controlled Clinical Studies. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Zolpidem Tartrate ZOLPIDEM TARTRATE ZINC3876

Comments